BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7685214)

  • 1. Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.
    Kamali F
    Clin Investig; 1993 May; 71(5):392-405. PubMed ID: 7685214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
    Fischl MA
    AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides.
    Pizzo PA
    Am J Med; 1990 May; 88(5B):16S-19S. PubMed ID: 2159704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapies with anti-retroviral agents in HIV and AIDS infections].
    Fernández-Cruz E
    Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
    Matthews SJ; Cersosimo RJ; Spivack ML
    Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy of human immunodeficiency virus-related disease.
    Mitsuya H; Yarchoan R; Kageyama S; Broder S
    FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.
    Adkins JC; Peters DH; Faulds D
    Drugs; 1997 Jun; 53(6):1054-80. PubMed ID: 9179531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in anti-retroviral therapy of adults.
    Khoo SH; Wilkins EG
    J Antimicrob Chemother; 1995 Feb; 35(2):245-62. PubMed ID: 7759389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
    Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
    AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy.
    Kavlick MF; Wyvill K; Yarchoan R; Mitsuya H
    J Infect Dis; 1998 Jun; 177(6):1506-13. PubMed ID: 9607827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of anti-HIV drugs in AIDS.
    Clumeck N
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():133-8. PubMed ID: 8407695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine: five years later.
    McLeod GX; Hammer SM
    Ann Intern Med; 1992 Sep; 117(6):487-501. PubMed ID: 1503352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of AIDS with combinations of antiretroviral agents.
    Merigan TC
    Am J Med; 1991 Apr; 90(4A):8S-17S. PubMed ID: 1850192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Wilde MI; Langtry HD
    Drugs; 1993 Sep; 46(3):515-578. PubMed ID: 7693435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.